General Information of Drug (ID: DMBSAWZ)

Drug Name
UB-312
Indication
Disease Entry ICD 11 Status REF
Parkinson disease 8A00.0 Phase 1 [1]
Drug Type
Vaccine
Cross-matching ID
TTD ID
DKUP06

References

1 ClinicalTrials.gov (NCT04075318) A Phase 1 Study to Evaluate the Safety, Tolerability, and Immunogenicity of UBITh? PD Immunotherapeutic Vaccine (UB-312) in Healthy Participants and Participants With Parkinson's Disease. U.S.National Institutes of Health.